Company Information
- Type:
- SME
- Country:
- Spain
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Delisted
- Reason for Delisting:
- Non-responsive
- Participant Since
- 14 July 2010 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 December 2023
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 10-Dec-2021 | Communication on Progress 2021 | Active |
| 22-Feb-2021 | Communication on Progress 2021 | Active |
| 06-Mar-2020 | Communication on Progress 2020 | Active |
| 07-Mar-2019 | Communication on Progress 2019 | Active |
| 14-Jun-2017 | Communication on Progress 2017 | Active |
| 06-Oct-2015 | Communication on Progress 2015 | Active |
| 08-Jul-2015 | Grace Letter | Not applicable |
| 08-Jul-2014 | Communication on Progress 2013 | Active |
| 12-Jul-2012 | 2012 Communication on Progress | Active |
| 14-Jul-2011 | 2011 Communication on Progress | Active |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.